University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Treatment > Drug Dosing Toolkit > Edurant

rilpivirine (Edurant)

Type of Drug: Nonnucleoside Reverse Transcriptase Inhibitor
Nonnucleoside reverse transcriptase inhibitors prevent HIV from using an enzyme called reverse transcriptase to make copies of itself. These drugs are also known as NNRTIs, nonnucleosides or "nonnukes."

Approved adult dosing

25 mg (one 25 mg tablet), once daily with a meal

  • Once daily

    photo of edurant pill

    Edurant (25 mg)

Notes on taking this medication

  • Take with a meal (do not take without food)
  • Edurant interacts with medicines for indigestion, heartburn, and ulcers, including medicines available over the counter; check with your medical provider before using these medicines
  • Edurant can interact with other drugs; persons using Edurant with those drugs may need an adjustment to their dose of the other drugs or avoid certain combinations; consult your medical provider

Possible side effects

  • Rash (usually is mild to moderate. If severe rash develops, contact your medical provider)
  • Nausea
  • Depression, mood changes

See accompanying chart: Tips for Common Side Effects

My doctor's instructions

Contents
Scroll over drug name to see other names for the drug.